Replies to post #107524 on Biotech Values

[kris_kade]

Yes. Now I have to find what all other BODs he is on :-)

[mcbio]

Re: AVNR - Nuedexta

Nuedexta, which has had a checkered development history, was discussed on this board more than six years ago (e.g. #msg-3877326). The drug is a fixed-dose combination of two generics: quinidine and dextromethorphan.

I don't own AVNR at all, but have some sentimental ties to AVNR because it was the first biotech I ever owned way back when it was known as Lidak. So, good to see some good news for them. I assume, given that Nuedexta is just a fixed-dose combo of two generics, that you don't see a huge market for this drug.

[go seek]

a look @ AVNR's chart late today,

a reason not to place GTC orders.

http://finance.yahoo.com/echarts?s=AVNR+Interactive#symbol=AVNR;range=1d